News
News
- Juul's booster reduces valuation to $19B - report
18:32 - TeleTrader - Women in Agribusiness to host summit in Europe in March 2020
18:04 - GlobeNewswire - Europe closes in red amid trade concerns
17:30 - TeleTrader - Questex’s Fierce Innovation Awards – LifeSciences Edition 2019 Announces Finalists, Precision NanoSystems Recognized
17:13 - GlobeNewswire - Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) at the 2019 American Society of Hematology (ASH) Annual Meeting in Orlando
17:00 - GlobeNewswire - Aprea Therapeutics Presents Results From U.S. Phase Ib/II Clinical Trial of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) at the 2019 American Society of Hematology (ASH) Annual Meeting in Orlando
17:00 - GlobeNewswire - Constellation Pharmaceuticals Provides Updated Preliminary Data from MANIFEST Clinical Trial with CPI-0610 in Oral and Poster Presentations at ASH
16:00 - GlobeNewswire - Agios Presents Updated Data for Mitapivat from Extension Phase of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency
16:00 - GlobeNewswire - WindMIL Therapeutics to Present Data Demonstrating Superior Efficacy of CAR-T cells using Marrow-Infiltrating Lymphocytes (CAR-MILs™) Compared to Peripheral Blood Lymphocytes at the 61st American Society of Hematology Annual Meeting and Exposition
16:00 - GlobeNewswire - EANS-DD: Josef Manner & Comp. AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR) EAE
15:38 - euro adhoc
Real-time